Show simple item record

dc.contributor.authorVillarreal, Alcibiades E.
dc.contributor.authorBarron, Rachel
dc.contributor.authorRao, KS Jagannatha
dc.contributor.authorBritton, Gabrielle B.
dc.date.accessioned2020-07-03T21:40:33Z
dc.date.available2020-07-03T21:40:33Z
dc.date.issued2014-01-01
dc.identifier.other10.3233/JAD-140144
dc.identifier.urihttp://repositorio-indicasat.org.pa/handle/123456789/167
dc.descriptionPersistent systemic hypoxia, a direct consequence of alterations in vascular function, can compromise the brain by increasing the risk of developing dementias such as Alzheimer’s disease (AD). Vascular contributions to cognitive impairment and AD in aged individuals are common, and several vascular risk factors for AD are linked to hypoxia. Clinical evidence confirms that structural and functional changes characteristic of AD pathology also occur following hypoxic-ischemic events such as stroke and traumatic brain injury. Studies with transgenic and non-transgenic mouse models reliably show that hypoxia increases the levels of amyloid- peptides that form the characteristic plaques in AD brains. Moreover, some studies suggest that vascular lesions also promote tau phosphorylation, modulate apolipoprotein E expression, and have more profound in effects in aged animals, but additional evidence is needed to establish these findings. Although the mechanisms underlying hypoxia-related effects remain unclear, controlled animal studies continue to reveal mechanistic aspects of the relationship between hypoxia and AD pathology that are necessary for therapeutic developments. The present review summarizes evidence from rodent studies regarding the effects of hypoxia on AD-related pathology and evaluates its impact on understanding human disease.en_US
dc.description.abstractPersistent systemic hypoxia, a direct consequence of alterations in vascular function, can compromise the brain by increasing the risk of developing dementias such as Alzheimer’s disease (AD). Vascular contributions to cognitive impairment and AD in aged individuals are common, and several vascular risk factors for AD are linked to hypoxia. Clinical evidence confirms that structural and functional changes characteristic of AD pathology also occur following hypoxic-ischemic events such as stroke and traumatic brain injury. Studies with transgenic and non-transgenic mouse models reliably show that hypoxia increases the levels of amyloid- peptides that form the characteristic plaques in AD brains. Moreover, some studies suggest that vascular lesions also promote tau phosphorylation, modulate apolipoprotein E expression, and have more profound in effects in aged animals, but additional evidence is needed to establish these findings. Although the mechanisms underlying hypoxia-related effects remain unclear, controlled animal studies continue to reveal mechanistic aspects of the relationship between hypoxia and AD pathology that are necessary for therapeutic developments. The present review summarizes evidence from rodent studies regarding the effects of hypoxia on AD-related pathology and evaluates its impact on understanding human disease.en_US
dc.language.isoenen_US
dc.subjectAmyloid-en_US
dc.subjectapolipoprotein Een_US
dc.subjectcerebral amyloid angiopathyen_US
dc.subjectcerebral hypoxiaen_US
dc.subjectischemiaen_US
dc.subjecttau proteinen_US
dc.titleThe effects of impaired cerebral circulation on Alzheimer's disease pathology: evidence from animal studies.en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record